Skip to content

13F-HR filed by DAFNA Capital Management LLC

DAFNA Capital Management LLC filed this 13F-HR for the quarter ended 2016-03-31, filed 2016-05-16, with 93 holding rows worth $115,926,000.

Accession
0001389933-16-000029
Filed
2016-05-16
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2016

A holdings report, 94 entries on the cover page, a total value of $115,926,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $115,926,000 with VALUE read as thousands by filing date, 13F file number 028-12327. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ATRICURE INC04963C209COM488,446$8,221,000thousands by filing date
AbbVie,Inc.00287Y109COM116,581$6,659,000thousands by filing date
NXSTAGE MEDICAL INC67072V103COMMON STOCK396,554$5,944,000thousands by filing date
VITAE PHARMACEUTICALS INC92847N103COM787,373$5,220,000thousands by filing date
RIGEL PHARMACEUTICALS INC766559603COMMON STOCK1,876,492$3,903,000thousands by filing date
DERMIRA INC24983L104COM171,881$3,554,000thousands by filing date
INSULET CORP COM45784P101Stock106,018$3,516,000thousands by filing date
ALDER BIOPHARMACEUTICALS INC014339105COM140,313$3,436,000thousands by filing date
MARINUS PHARMACEUTICALS INC56854Q101COM566,498$3,048,000thousands by filing date
NEUROCRINE BIOSCIENCES INC64125C109COM76,300$3,018,000thousands by filing date
NOVAVAX INC670002104COMMON STOCK553,500$2,856,000thousands by filing date
BIOTELEMETRY INC090672106COM235,645$2,752,000thousands by filing date
LAKEFRONT BIOTHERAPEUTICS NV36315X101SPON ADR65,568$2,742,000thousands by filing date
REGULUS THERAPEUTICS INC75915K101COM391,500$2,713,000thousands by filing date
APPLIED GENETIC TECHNOL CORP03820J100COM167,192$2,337,000thousands by filing date
INSULET CORP45784PAD3NOTE 2.000% 6/12,407,000$2,330,000thousands by filing dateprincipal
AERIE PHARMACEUTICALS INC00771V108COM179,769$2,186,000thousands by filing date
MASIMO CORP COM574795100Stock46,010$1,925,000thousands by filing date
UNIQURE NVN90064101SHS158,907$1,888,000thousands by filing date
ACHILLION PHARMACEUTICALS IN00448Q201COM236,500$1,826,000thousands by filing date
CARA THERAPEUTICS INC140755109COM267,046$1,661,000thousands by filing date
PROTALIX BIOTHERAPEUTICS INC74365AAB7NOTE 4.500% 9/12,500,000$1,644,000thousands by filing dateprincipal
ISHARES TR464287556ISHARES BIOTECH6,000$1,565,000thousands by filing date
STEREOTAXIS INC85916J409COMMON STOCK1,372,862$1,510,000thousands by filing date
BIOSPECIFICS TECHNOLOGIES090931106COM39,704$1,382,000thousands by filing date
XENON PHARMACEUTICALS INC COM98420N105Stock193,195$1,350,000thousands by filing date
RADIUS HEALTH INC750469207COM NEW42,600$1,339,000thousands by filing date
CELYAD ONCOLOGY SA151205200ADR30,000$1,325,000thousands by filing date
LDR HLDG CORP50185U105COM50,300$1,282,000thousands by filing date
SPECTRANETICS CORP84760C107COM79,812$1,159,000thousands by filing date
NOVADAQ TECHNOLOGIES INC COMMON66987G102COM101,841$1,129,000thousands by filing date
DERMA SCIENCES INC249827502COM PAR $.01353,718$1,097,000thousands by filing date
ARDELYX INC039697107COM140,265$1,090,000thousands by filing date
LOXO ONCOLOGY INC548862101COM39,000$1,066,000thousands by filing date
Johnson & Johnson478160104COM9,400$1,017,000thousands by filing date
MACROGENICS INC556099109COM54,200$1,016,000thousands by filing date
ASCENDIS PHARMA A/S DKK 1.0 AD04351P101SPONSORED ADR53,241$988,000thousands by filing date
LIPOCINE INC NEW53630X104CMN95,731$972,000thousands by filing date
MEDICINOVA INC58468P206COM NEW125,000$918,000thousands by filing date
DISCOVERY LABORATORIES INC N254668502COM PAR533,358$891,000thousands by filing date
SYNERGY PHARMACEUTICALS DEL871639308COM NEW294,563$813,000thousands by filing date
FOAMIX PHARMACEUTICALS LTDM46135105SHS118,671$774,000thousands by filing date
ALDEYRA THERAPEUTICS INC01438T106COM176,232$738,000thousands by filing date
ZOGENIX INC.98978L204Common Stock79,400$734,000thousands by filing date
AVALANCHE BIOT05337G107Common Stock140,600$727,000thousands by filing date
ADAPTIMMUNE THERAPEUTICS PLC00653A107SPONDS ADR88,100$716,000thousands by filing date
ADAMAS PHARMACEUTICALS INC00548A106COM47,500$687,000thousands by filing date
CAREDX INC14167L103COM136,047$675,000thousands by filing date
TOBIRA THERAPEUTICS INC COM88883P101COM81,402$666,000thousands by filing date
ESSA PHARMA INC29668H104COM202,496$662,000thousands by filing date
DICERNA PHARMACEUTICALS INC253031108COM120,600$646,000thousands by filing date
CYNAPSUS THERAPEUTICS INC23257Y859COM PAR NO PAR52,941$646,000thousands by filing date
EXACTECH INC30064E109COM31,636$641,000thousands by filing date
EDGE THERAPEUTICS INC279870109COM69,177$633,000thousands by filing date
SCYNEXIS INC COM NEW811292101Common Stock156,904$632,000thousands by filing date
SYNERON MEDICAL LTDM87245102ORD85,947$628,000thousands by filing date
AKEBIA THERAPEUTICS INC00972D105COMMON STOCK65,700$592,000thousands by filing date
BEONE MEDICINES LTD SPONSORED ADS07725L102ADR20,000$586,000thousands by filing date
IRONWOOD PHARMA46333XAC2NOTE 2.25% 15-Jun-2022 144A SR UNSECURED CONV600,000$548,000thousands by filing dateprincipal
TARGACEPT INC87611RAA6NOTE 2/1530,821$531,000thousands by filing dateprincipal
BLUEBIRD BIO INC09609G100COM12,000$510,000thousands by filing date
CARDICA INC14141R309COM NEW140,275$499,000thousands by filing date
ENDOLOGIX INC29266SAB2NOTE 3.25011/0500,000$496,000thousands by filing dateprincipal
INTEC PHARMA LTD JERUSALEMM53644106SHS119,296$491,000thousands by filing date
Arbutus Biopharma Corp03879J100Common Shares, without par value115,230$476,000thousands by filing date
ABEONA THERAPEUTICS INC00289Y107COM181,818$465,000thousands by filing date
BIOCRYST PHARMACEUTICALS INC COM09058V103Stock149,642$423,000thousands by filing date
NEOS THERAPEUTICS INC64052L106COM38,873$419,000thousands by filing date
CYNAPSUS THERAPEUTICS INC23257Y156COM33,995$416,000thousands by filing date
NEMUS BIOSCIENCE INC64046J100COM580,382$400,000thousands by filing date
CYTOKINETICS INC23282W605COM NEW55,600$392,000thousands by filing date
COGENTIX MED INC COM19243A104Stock352,882$388,000thousands by filing date
VTV THERAPEUTICS INC CL A918385105Stock73,000$377,000thousands by filing date
Tandem Diabetes Care, Inc.875372104COM36,551$318,000thousands by filing date
CHECK CAP LTDM2361E112SHS89,220$245,000thousands by filing date
SUNESIS PHARMACEUTICALS INC867328601COM NEW423,336$229,000thousands by filing date
VENAXIS INC92262A206COM NEW74,350$201,000thousands by filing date
STEMCELLS INC85857R204COM NEW699,563$182,000thousands by filing date
AFFIMED N VN01045108COM46,701$175,000thousands by filing date
TENAX THERAPEUTICS INC88032L100COM79,509$163,000thousands by filing date
BIOPHARMX CORP09072X101COM146,800$160,000thousands by filing date
CATALYST14888D109COM70,903$119,000thousands by filing date
PIERIS PHARMACEUTICALS INC720795103COM50,214$95,000thousands by filing date
GENVEC INC NEW37246C307cs95,800$77,000thousands by filing date
CEL SCI CORP150837508COM PAR $0.01127,482$68,000thousands by filing date
Sierra Oncology, Inc.74346L101common10,000$67,000thousands by filing date
GALMED PHARMACEUTICALS LTDM47238106SHS13,488$66,000thousands by filing date
AKARI THERAPEUTICS PLC00972G108ADR4,741$66,000thousands by filing date
NIVALIS THERAPEUTICS INC65481J109COM15,000$63,000thousands by filing date
CHECK CAP LTDM2361E120*W EXP 02/28/20253,690$42,000thousands by filing date
ANTARES PHARMA INC036642106COM45,000$39,000thousands by filing date
ENTEROMEDICS INC29365M307COM PAR 0.0133,334$32,000thousands by filing date
NEURODERM LTDM74231107ORD SHS1,202$17,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001389933-16-000029this filing2016-05-16acceptance time not in the bulk data set